Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.

Hayashi, Kazuhiko

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver Oct 2011 - 1359-65 p. digital

Publication Type: Journal Article; Multicenter Study

1478-3231

10.1111/j.1478-3231.2011.02571.x doi


Aged
Amino Acid Substitution
Antiviral Agents--therapeutic use
Biopsy
Chi-Square Distribution
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Genotype
Hepacivirus--drug effects
Hepatitis C, Chronic--complications
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Interferons
Interleukins--genetics
Japan
Liver Cirrhosis--drug therapy
Logistic Models
Male
Middle Aged
Mutation
Patient Selection
Phenotype
Polyethylene Glycols--therapeutic use
Polymorphism, Single Nucleotide
RNA, Viral--blood
Recombinant Proteins--therapeutic use
Ribavirin--therapeutic use
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Viral Core Proteins--genetics
Viral Load
Viral Nonstructural Proteins--genetics